Pharmaceuticals, Biotechnology and Life Sciences
Biocom’s 2019 Economic Impact Report Highlights the Steady Growth of the Industry Throughout the State SAN DIEGO–(BUSINESS WIRE)–#BayArea—California’s life science…
-Targeted antibody elicits responses in both FGFR3 wild-type and mutant/fusion patients- -Favorable tolerability and safety profile and prolonged treatment duration-…
Highlights: 42% investigator-assessed ORR achieved in patients with advanced PEComa – a rare sarcoma with no currently approved therapy First…
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) (along with its subsidiaries together…
With up to six years of follow-up, results from the RESONATETM study showed patients with previously treated CLL receiving ibrutinib…
Dr. Summers to help guide Cerevance’s Drug Discovery and Development Efforts BOSTON–(BUSINESS WIRE)–#CNS–Cerevance, a clinical stage biopharmaceutical company advancing new…
Acquisition allows KD Pharma to further expand its leading position in the omega-3 pharmaceutical market BIOGGIO, Switzerland–(BUSINESS WIRE)–KD Pharma Group…
New ovarian cancer test combines AI and Mass Spec in an effort to better identify cancerous ovarian tumors from benign…
ZYNTEGLO is the first gene therapy approved for transfusion-dependent β-thalassemia (TDT) European marketing authorization for ZYNTEGLO follows the fastest assessment…
ZYNTEGLO is the first gene therapy approved for transfusion-dependent β-thalassemia (TDT) European marketing authorization for ZYNTEGLO follows the fastest assessment…